TickerFactsScreenerDevelopers

Matinas BioPharma Holdings, Inc. (MTNB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $424.4K2013: $10.84M2014: $2.59M2015: $3.23M2016: $4.11M2017: $7.31M2018: $12.45M2019: $22.17M2020: $12.43M2021: $21.03M2022: $6.83M2023: $4.79M2024: $7.28M2025: $4.00M$4.00M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$4.00M-45.1%
2024$7.28M+52.2%
2023$4.79M-29.9%
2022$6.83M-67.5%
2021$21.03M+69.2%
2020$12.43M-43.9%
2019$22.17M+78.1%
2018$12.45M+70.4%
2017$7.31M+78.0%
2016$4.11M+27.2%
2015$3.23M+24.6%
2014$2.59M-76.1%
2013$10.84M+2454.5%
2012$424.4K—